Endologix (ELGX) PT Lowered to $3.75 at Leerink Partners
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Endologix (ELGX) PT Lowered to $4 at BMO Capital
August 13, 2018 8:26 AM EDTBMO Capital analyst Joanne Wuensch lowered the price target on Endologix (NASDAQ: ELGX) to $4.00 (from $6.50) while maintaining a Market Perform rating.
... MorePiper Jaffray Downgrades Endologix (ELGX) to Neutral
August 10, 2018 5:11 AM EDTPiper Jaffray downgraded Endologix (NASDAQ: ELGX) from Overweight to Neutral with a price target of $4.75 (from $7.00).
Analyst Matt O''Brien comments "This afternoon, Endologix reported Q2 results that were a little light of our estimates. The big news from the release and conference call is... More
Endologix (ELGX) Posts Q2 Loss of $0.28/Share; Lowers Outlook
August 9, 2018 4:43 PM EDTEndologix (NASDAQ: ELGX) reported Q2 EPS of ($0.28), $0.13 worse than the analyst estimate of ($0.15). Revenue for the quarter came in at $44.7 million versus the consensus estimate of $44.45 million.
GUIDANCE:
Endologix sees FY2018 revenue of $145-155 million, versus prior of $170-$180... More
